Landscapes / Targets
SARS-CoV-2 spike protein
5 drugs act on SARS-CoV-2 spike protein, in 5 active trials · Any stage · updated 20 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Sanofi · Public SNY |
Approved in the EU | 26 Nov 2026soonPhase 4 trial completes | ||
| Next date | 26 Nov 2026 · Phase 4 trial completes | ||||
| Also tested for | COVID-19 | ||||
| Open drug page | |||||
— |
Sinocelltech · Public 688520.SS |
Phase 2/3 | — | ||
| Also tested for | COVID-19, SARS-CoV-2 | ||||
| Open drug page | |||||
— |
Phase 1 | Nov 2026soonPhase 1 trial completes | |||
| Next date | Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | COVID - 19, SARS CoV-2 | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Prevention of COVID-19 Variant (Omicron JN.1) | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | covid19 Infection, Influenza, Human | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · openFDA updated 20 Nov 2026